학술논문
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study
Document Type
Article
Author
Source
In: eClinicalMedicine . (eClinicalMedicine, May 2023, 59)
Subject
Language
English
ISSN
25895370